Intellia Therapeutics, Inc. (NTLA) Stock Analysis — Valuation, Growth & Financial Health

Five-Pillar Analysis for NTLA

TopTier Strategy breaks every stock down into five clear pillars — so you can quickly see what makes Intellia Therapeutics, Inc. a strong or weak investment candidate.

▲ Valuation

Is NTLA priced fairly?

P/E, EV/EBITDA, P/B, and free cash flow yield — versus sector medians and NTLA's own history. Our valuation engine flags whether Intellia Therapeutics, Inc. is trading rich, fair, or cheap.

▲ Profitability

How efficient is Intellia Therapeutics, Inc.?

Gross margin, operating margin, net margin — and how they're trending. Stable or expanding margins signal pricing power; declining margins are an early warning.

▲ Financial Health

Can NTLA survive a downturn?

Debt-to-equity, current ratio, quick ratio, and interest coverage. We screen Intellia Therapeutics, Inc.'s balance sheet for stress and flag liquidity or leverage risk.

▲ Returns

What's NTLA earning on capital?

Return on Equity, Return on Invested Capital, and Return on Assets. We compare Intellia Therapeutics, Inc.'s capital efficiency to peers — and check leverage to make sure ROE isn't financial-engineering noise.

▲ Growth

Is Intellia Therapeutics, Inc. expanding?

Revenue growth, EPS growth, and free cash flow growth — over 1, 3, and 5 years. We separate genuine operating growth from buyback-driven EPS gains.

→ Get the Full Picture

See the complete NTLA breakdown

Sign up free to unlock Intellia Therapeutics, Inc.'s full five-pillar analysis with live financial data, peer comparisons, and historical context.

Sign up free →

Frequently Asked Questions about NTLA

Quick answers to the most common questions about Intellia Therapeutics, Inc..

What does Intellia Therapeutics, Inc. (NTLA) do?

Intellia Therapeutics, Inc. is a publicly traded company under the ticker symbol NTLA. Sign up to TopTier Strategy to view a full business overview — including segments, competitive position, and how revenue is generated.

How do I analyze NTLA stock?

The five-pillar framework — Valuation, Profitability, Financial Health, Returns, and Growth — is the cleanest way to evaluate any stock, including NTLA. Each pillar uses standardized metrics that let you compare Intellia Therapeutics, Inc. to its peers and to its own history.

Is NTLA a good stock to buy?

Whether Intellia Therapeutics, Inc. fits your portfolio depends on your time horizon, risk tolerance, and investing style. TopTier Strategy gives you the structured data — valuation, profitability, balance sheet health, returns on capital, and growth — to make that decision with conviction.

Where can I see NTLA's financial data?

Sign up free at TopTier Strategy to access Intellia Therapeutics, Inc.'s complete financial profile, including historical metrics, peer comparisons, and our five-pillar score breakdown.

Popular Stocks

Other widely-followed stocks investors research on TopTier Strategy.

Intellia Therapeutics, Inc. (NTLA)